Lv12
50 积分 2022-11-10 加入
Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes
3小时前
已完结
Development, validation and application of a UPLC-MS/MS method for simultaneous quantification of OPC-61815 and its metabolites tolvaptan, DM-4103 and DM-4107 in human plasma
3小时前
已完结
Prediction of molecular interactions and physicochemical properties relevant for vasopressin V2 receptor antagonism
2天前
已完结
Vasopressin receptor antagonists: a patent summary (2018-2022)
2天前
已完结
Structural basis of tolvaptan binding to the vasopressin V2 receptor
2天前
已完结
Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease
3天前
已完结
Systems‐based digital twins to help characterize clinical dose–response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL
3天前
已完结
Digital twins in medicine
3天前
已完结
Embracing the future of medicine with virtual patients
4天前
已完结
Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins
14天前
已完结
皖公网安备34019202002308
